Insufficient scRNA-seq data for expression of TIRAP at single-cell level.
Insufficient scRNA-seq data for expression of TIRAP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 235.43 | 359 / 359 | 100% | 6.21 | 286 / 286 |
esophagus | 100% | 275.38 | 1444 / 1445 | 100% | 7.29 | 183 / 183 |
prostate | 100% | 319.00 | 245 / 245 | 100% | 5.98 | 501 / 502 |
intestine | 100% | 318.33 | 966 / 966 | 99% | 5.22 | 524 / 527 |
breast | 100% | 272.73 | 459 / 459 | 99% | 5.67 | 1109 / 1118 |
pancreas | 100% | 207.81 | 327 / 328 | 99% | 4.21 | 177 / 178 |
bladder | 100% | 331.19 | 21 / 21 | 99% | 4.02 | 497 / 504 |
skin | 100% | 282.40 | 1809 / 1809 | 99% | 5.05 | 465 / 472 |
thymus | 100% | 248.26 | 653 / 653 | 98% | 3.56 | 593 / 605 |
lung | 99% | 218.86 | 571 / 578 | 98% | 4.46 | 1137 / 1155 |
liver | 100% | 251.96 | 226 / 226 | 97% | 3.67 | 394 / 406 |
brain | 97% | 136.36 | 2554 / 2642 | 100% | 3.88 | 704 / 705 |
kidney | 100% | 196.70 | 89 / 89 | 96% | 3.76 | 863 / 901 |
adrenal gland | 100% | 279.57 | 258 / 258 | 94% | 3.98 | 216 / 230 |
uterus | 100% | 323.71 | 170 / 170 | 91% | 2.91 | 416 / 459 |
ovary | 100% | 356.99 | 180 / 180 | 90% | 2.77 | 389 / 430 |
adipose | 100% | 240.15 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 257.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 335.06 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.96 | 1 / 1 |
muscle | 99% | 149.35 | 798 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 5.05 | 78 / 80 |
heart | 96% | 150.44 | 825 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 2.48 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 3.46 | 27 / 29 |
peripheral blood | 92% | 219.96 | 851 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0071221 | Biological process | cellular response to bacterial lipopeptide |
GO_2000340 | Biological process | positive regulation of chemokine (C-X-C motif) ligand 1 production |
GO_0032738 | Biological process | positive regulation of interleukin-15 production |
GO_0045087 | Biological process | innate immune response |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0035665 | Biological process | TIRAP-dependent toll-like receptor 4 signaling pathway |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_2000343 | Biological process | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0034137 | Biological process | positive regulation of toll-like receptor 2 signaling pathway |
GO_0045088 | Biological process | regulation of innate immune response |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0030099 | Biological process | myeloid cell differentiation |
GO_0034145 | Biological process | positive regulation of toll-like receptor 4 signaling pathway |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0032648 | Biological process | regulation of interferon-beta production |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0034141 | Biological process | positive regulation of toll-like receptor 3 signaling pathway |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0032587 | Cellular component | ruffle membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0031234 | Cellular component | extrinsic component of cytoplasmic side of plasma membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0035663 | Molecular function | Toll-like receptor 2 binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0035662 | Molecular function | Toll-like receptor 4 binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TIRAP |
Protein name | TIR domain containing adaptor protein Toll/interleukin-1 receptor domain-containing adapter protein (TIR domain-containing adapter protein) (Adaptor protein Wyatt) (MyD88 adapter-like protein) (MyD88-2) |
Synonyms | MAL |
Description | FUNCTION: Adapter involved in TLR2, TLR4 and RAGE signaling pathways in the innate immune response. Acts via IRAK2 and TRAF-6, leading to the activation of NF-kappa-B, MAPK1, MAPK3 and JNK, and resulting in cytokine secretion and the inflammatory response. Positively regulates the production of TNF-alpha (TNF) and interleukin-6 (IL6). . |
Accessions | ENST00000479770.2 [P58753-1] ENST00000700491.1 [P58753-2] P58753 ENST00000700495.1 ENST00000700488.1 [P58753-1] ENST00000700489.1 [P58753-1] A0A8V8TPR1 ENST00000392680.6 [P58753-1] ENST00000700492.1 [P58753-2] ENST00000700490.1 [P58753-1] ENST00000488598.5 ENST00000392678.7 [P58753-2] ENST00000392679.6 [P58753-1] F5H2K1 |